Management of aminoglycosides in the intensive care unit.

Management of aminoglycosides in the intensive care unit.

Item
http://www.wikidata.org/entity/Q42908869
New developments in aminoglycoside therapy and ototoxicityEndotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity.Gentamicin differentially alters cellular metabolism of cochlear hair cells as revealed by NAD(P)H fluorescence lifetime imaging.Therapeutic drug monitoring of amikacin in septic patients.Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjectsHow aminoglycosides are used in critically ill patients in a teaching hospital in North of IranAminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered.Amikacin: Uses, Resistance, and Prospects for Inhibition.
P2860

Management of aminoglycosides in the intensive care unit.

Item
http://www.wikidata.org/entity/Q42908869
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Management of aminoglycosides in the intensive care unit.
@en
Management of aminoglycosides in the intensive care unit.
@nl
type
label
Management of aminoglycosides in the intensive care unit.
@en
Management of aminoglycosides in the intensive care unit.
@nl
prefLabel
Management of aminoglycosides in the intensive care unit.
@en
Management of aminoglycosides in the intensive care unit.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Management of aminoglycosides in the intensive care unit.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921